Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2024-01-09 Director's Dealing
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2024-01-09 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, which is used for reporting unscheduled material events or corporate changes. The text includes an Investor Presentation attached as Exhibit 99.1 and a press release about an investment and strategic relationship attached as Exhibit 99.2. The document does not contain detailed financial statements or comprehensive financial analysis but rather announces events and provides supplementary materials. The presence of an Investor Presentation as an exhibit and the nature of the report indicate this is a Capital/Financing Update or similar event disclosure. Given the announcement of an investment and strategic relationship, the most appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a full financial report but a current report with investor presentation and press release attachments.
2024-01-04 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2023-12-22 English
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2023-12-21 English
Regulatory Filings 2023
Regulatory Filings
2023-12-19 English
8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated November 29, 2023, by OraSure Technologies, Inc. The content focuses on the change in the company's independent registered public accounting firm, detailing the dismissal of KPMG LLP and appointment of Grant Thornton LLP as auditors for the next fiscal year. It includes disclosures about prior audit reports, disagreements, and reportable events related to internal controls. The document also references a letter from KPMG filed as an exhibit. There are no financial statements or detailed financial data presented; rather, it is an announcement of a change in the company's auditor and related disclosures. This fits the category of Regulatory Filings (RNS), as it is a regulatory announcement that does not constitute a full audit report or annual report itself.
2023-12-05 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.